About the Company
atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. with its immune repertoire capture™ (irc™) technology, atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health. if you are interested in becoming part of the atreca team, our open positions can be found at: http://www.atreca.com/careers/
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BCEL News
Atreca, Inc. (BCEL)
CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (“Atreca”) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics ...
Atreca, Inc. Class A
Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages ...
Atreca Inc Announces Executive Departures and Consulting Agreements
Atreca Inc (BCEL) has released an update to notify the public and investors about its officers. As Atreca, Inc. scales down ...
Atreca Inc. general counsel sells shares worth $2,645
Atreca Inc . (NASDAQ:OTC:BCEL) disclosed a recent stock transaction involving its General Counsel & Secretary, Courtney Phillips, who sold shares to cover tax withholding obligations. The ...
Atreca Inc. Cl A
1 Day BCEL -1.11% DJIA -0.06% Russell 2K -0.77% Health Care/Life Sciences -0.38% ...
Atreca, Inc. (BCEL) Latest Stock News & Headlines - Yahoo Finance
For example, biotech and... Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart ...
Atreca, Inc. (BCEL) stock price, news, quote & history – Yahoo Finance
CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (“Atreca”) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery ...
Atreca CEO sells shares to cover tax obligations
Atreca, Inc. (NASDAQ:OTC:BCEL) President and CEO, John A. Orwin, sold shares worth approximately $8,597 on September 1, 2023, to cover tax withholding obligations associated with the vesting of ...
Atreca Inc Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Atreca Inc. general counsel sells shares worth $2,645
Atreca Inc . (NASDAQ:OTC:BCEL) disclosed a recent stock transaction involving its General Counsel & Secretary, Courtney Phillips, who sold shares to cover tax withholding obligations. The transaction, ...
Loading the latest forecasts...